NUDT22
gene geneOn this page
Also known as MGC13045
Summary
NUDT22 (nudix hydrolase 22, HGNC:28189) is a protein-coding gene on chromosome 11q13.1, encoding Uridine diphosphate glucose pyrophosphatase NUDT22 (Q9BRQ3). Hydrolyzes UDP-glucose to glucose 1-phosphate and UMP and UDP-galactose to galactose 1-phosphate and UMP.
Enables UDP-sugar diphosphatase activity and metal ion binding activity. Located in nucleoplasm.
Source: NCBI Gene 84304 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_032344
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28189 |
| Approved symbol | NUDT22 |
| Name | nudix hydrolase 22 |
| Location | 11q13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC13045 |
| Ensembl gene | ENSG00000149761 |
| Ensembl biotype | protein_coding |
| Entrez | 84304 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 6 protein_coding, 5 retained_intron, 3 nonsense_mediated_decay
ENST00000279206, ENST00000422364, ENST00000428347, ENST00000441250, ENST00000534929, ENST00000535000, ENST00000537094, ENST00000537707, ENST00000539325, ENST00000543358, ENST00000543501, ENST00000545184, ENST00000934227, ENST00000934228
RefSeq mRNA: 4 — MANE Select: NM_032344
NM_001128612, NM_001128613, NM_001271831, NM_032344
CCDS: CCDS44640, CCDS8061
Canonical transcript exons
ENST00000279206 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000728414 | 64229247 | 64229344 |
| ENSE00001139190 | 64226635 | 64227132 |
| ENSE00001196025 | 64227568 | 64227666 |
| ENSE00003463819 | 64229478 | 64229571 |
| ENSE00003682817 | 64229850 | 64230016 |
| ENSE00003888806 | 64226274 | 64226427 |
Expression profiles
Bgee: expression breadth ubiquitous, 237 present calls, max score 97.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.7047 / max 342.1206, expressed in 1814 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114873 | 17.2682 | 1807 |
| 114874 | 3.0216 | 1587 |
| 114875 | 1.7258 | 617 |
| 114872 | 0.5695 | 302 |
| 114876 | 0.1195 | 31 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 97.69 | gold quality |
| apex of heart | UBERON:0002098 | 97.55 | gold quality |
| granulocyte | CL:0000094 | 96.50 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.00 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.96 | gold quality |
| transverse colon | UBERON:0001157 | 95.44 | gold quality |
| spleen | UBERON:0002106 | 95.16 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.11 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 95.01 | gold quality |
| body of stomach | UBERON:0001161 | 94.99 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.91 | gold quality |
| body of pancreas | UBERON:0001150 | 94.87 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.81 | gold quality |
| right lobe of liver | UBERON:0001114 | 94.60 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.58 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.55 | gold quality |
| cardiac atrium | UBERON:0002081 | 94.45 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.40 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.23 | gold quality |
| small intestine | UBERON:0002108 | 94.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.07 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.93 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.84 | gold quality |
| cortex of kidney | UBERON:0001225 | 93.73 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.67 | gold quality |
| heart | UBERON:0000948 | 93.58 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.58 | gold quality |
| thyroid gland | UBERON:0002046 | 93.54 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.29 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- NUDT22 promotes cancer growth through pyrimidine salvage. (PMID:36871087)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nudt22 | ENSDARG00000071671 |
| mus_musculus | Nudt22 | ENSMUSG00000037349 |
| rattus_norvegicus | Nudt22 | ENSRNOG00000021158 |
Protein
Protein identifiers
Uridine diphosphate glucose pyrophosphatase NUDT22 — Q9BRQ3 (reviewed: Q9BRQ3)
Alternative names: Nucleoside diphosphate-linked moiety X motif 22
All UniProt accessions (5): Q9BRQ3, F5H1N0, G3V1M6, H0YGG2, J3KQJ3
UniProt curated annotations — full annotation on UniProt →
Function. Hydrolyzes UDP-glucose to glucose 1-phosphate and UMP and UDP-galactose to galactose 1-phosphate and UMP. Preferred substrate is UDP-glucose.
Similarity. Belongs to the Nudix hydrolase family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BRQ3-1 | 1 | yes |
| Q9BRQ3-2 | 2 | |
| Q9BRQ3-3 | 3 |
RefSeq proteins (4): NP_001122084, NP_001122085, NP_001258760, NP_115720* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000086 | NUDIX_hydrolase_dom | Domain |
| IPR055295 | NUDT22/NUDT9-like | Family |
UniProt features (56 total): helix 15, strand 12, binding site 10, turn 5, sequence variant 4, mutagenesis site 3, splice variant 2, chain 1, domain 1, region of interest 1, sequence conflict 1, short sequence motif 1
Structure
Experimental structures (PDB)
33 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5RKZ | X-RAY DIFFRACTION | 1.38 |
| 5R53 | X-RAY DIFFRACTION | 1.4 |
| 5R57 | X-RAY DIFFRACTION | 1.44 |
| 5R5A | X-RAY DIFFRACTION | 1.44 |
| 5LF9 | X-RAY DIFFRACTION | 1.45 |
| 5R52 | X-RAY DIFFRACTION | 1.48 |
| 5R55 | X-RAY DIFFRACTION | 1.48 |
| 5R5S | X-RAY DIFFRACTION | 1.5 |
| 5R56 | X-RAY DIFFRACTION | 1.51 |
| 5R5B | X-RAY DIFFRACTION | 1.53 |
| 5R5P | X-RAY DIFFRACTION | 1.53 |
| 5R5E | X-RAY DIFFRACTION | 1.58 |
| 5R5K | X-RAY DIFFRACTION | 1.6 |
| 5R5M | X-RAY DIFFRACTION | 1.6 |
| 5R5F | X-RAY DIFFRACTION | 1.63 |
| 5R5L | X-RAY DIFFRACTION | 1.63 |
| 5R51 | X-RAY DIFFRACTION | 1.65 |
| 5R5D | X-RAY DIFFRACTION | 1.65 |
| 5R5R | X-RAY DIFFRACTION | 1.65 |
| 5R5C | X-RAY DIFFRACTION | 1.68 |
| 5R5I | X-RAY DIFFRACTION | 1.7 |
| 5R5Q | X-RAY DIFFRACTION | 1.71 |
| 5R5G | X-RAY DIFFRACTION | 1.77 |
| 5R54 | X-RAY DIFFRACTION | 1.79 |
| 5R5H | X-RAY DIFFRACTION | 1.79 |
| 5R5O | X-RAY DIFFRACTION | 1.79 |
| 5LOU | X-RAY DIFFRACTION | 1.8 |
| 5R50 | X-RAY DIFFRACTION | 1.87 |
| 5R5N | X-RAY DIFFRACTION | 1.87 |
| 5R58 | X-RAY DIFFRACTION | 1.98 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BRQ3-F1 | 93.28 | 0.83 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (10): 158; 189; 193; 274; 56; 87; 139; 144; 151; 156
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 156 | abolishes enzyme activity with udp-galactose. |
| 189 | abolishes enzyme activity with udp-galactose. |
| 193 | abolishes enzyme activity with udp-galactose. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 61 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, chr11q13, CAGCTG_AP4_Q5, MODULE_313, HNF4_DR1_Q3, PPAR_DR1_Q2, ELK1_01, ACTTTAT_MIR1425P, NUYTTEN_EZH2_TARGETS_DN, SCGGAAGY_ELK1_02, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, FORTSCHEGGER_PHF8_TARGETS_DN
GO Biological Process (0):
GO Molecular Function (5): UDP-sugar diphosphatase activity (GO:0008768), metal ion binding (GO:0046872), GDP-mannose hydrolase activity (GO:0052751), protein binding (GO:0005515), hydrolase activity (GO:0016787)
GO Cellular Component (1): nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| pyrophosphatase activity | 2 |
| cation binding | 1 |
| binding | 1 |
| catalytic activity | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
740 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NUDT22 | NUDT14 | O95848 | 774 |
| NUDT22 | NUDT17 | P0C025 | 745 |
| NUDT22 | NUDT12 | Q9BQG2 | 724 |
| NUDT22 | NUDT5 | Q9UKK9 | 718 |
| NUDT22 | NUDT18 | Q6ZVK8 | 703 |
| NUDT22 | NUDT2 | P50583 | 676 |
| NUDT22 | NUDT1 | P36639 | 641 |
| NUDT22 | PPP1R14B | Q96C90 | 609 |
| NUDT22 | NUDT3 | O95989 | 592 |
| NUDT22 | NUDT6 | P53370 | 591 |
| NUDT22 | NUDT15 | Q9NV35 | 586 |
| NUDT22 | NUDT4B | A0A024RBG1 | 580 |
| NUDT22 | NUDT9 | Q9BW91 | 579 |
| NUDT22 | NUDT21 | O43809 | 572 |
| NUDT22 | NUDT7 | P0C024 | 544 |
IntAct
82 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NUDT22 | TLE5 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TLE5 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.670 |
| NUDT22 | RUSC1 | psi-mi:“MI:0915”(physical association) | 0.600 |
| NUDT22 | ZNF19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF648 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB33 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCF4 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DNAL4 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF143 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| INCA1 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF398 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USP54 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUDT22 | ZMYND12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO1 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DDIT4L | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL26 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| NUDT22 | LHX3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF343 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUDT22 | WDR54 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUDT22 | ZNF581 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARID5A | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF655 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF19 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLE5 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATA7 | NUDT22 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (28): NUDT22 (Two-hybrid), NUDT22 (Affinity Capture-MS), NUDT22 (Affinity Capture-MS), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), NUDT22 (Two-hybrid), FAM154A (Two-hybrid), ZNF19 (Two-hybrid), RUSC1 (Two-hybrid), USP54 (Two-hybrid)
ESM2 similar proteins: A2AA28, A4FV42, A4FV98, A6NDG6, D3YWP0, D3ZVU9, O15315, O35719, O70277, O75382, O94759, P21964, P57775, P81799, Q2TBS1, Q3UGX3, Q4R3I0, Q5E9V4, Q5H879, Q5RJL2, Q5SUV1, Q6DC64, Q7Z624, Q86WI3, Q86XA0, Q8BNV1, Q8C436, Q8CIW5, Q8IZ69, Q8N8L6, Q8N9F0, Q8VCX6, Q8WXB1, Q96AZ1, Q96FB5, Q96RR1, Q9BQD7, Q9BRQ3, Q9BUU2, Q9CQL0
Diamond homologs: Q2TBI8, Q6P9U1, Q8VYR2, Q9BRQ3, Q9DD16
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1376 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:64229240:A:AG | acceptor_gain | 1.0000 |
| 11:64229242:C:A | acceptor_gain | 1.0000 |
| 11:64229340:GTCCA:G | donor_gain | 1.0000 |
| 11:64229341:TCCA:T | donor_gain | 1.0000 |
| 11:64229345:G:GG | donor_gain | 1.0000 |
| 11:64229349:G:GG | donor_gain | 1.0000 |
| 11:64226005:C:A | donor_gain | 0.9900 |
| 11:64226028:AGGC:A | donor_gain | 0.9900 |
| 11:64227579:T:TA | acceptor_gain | 0.9900 |
| 11:64229240:ACC:A | acceptor_gain | 0.9900 |
| 11:64229242:CGCA:C | acceptor_loss | 0.9900 |
| 11:64229243:GCAG:G | acceptor_loss | 0.9900 |
| 11:64229244:CAGGT:C | acceptor_loss | 0.9900 |
| 11:64229245:A:AG | acceptor_gain | 0.9900 |
| 11:64229245:A:C | acceptor_loss | 0.9900 |
| 11:64229245:AGGT:A | acceptor_gain | 0.9900 |
| 11:64229246:G:A | acceptor_loss | 0.9900 |
| 11:64229246:G:GG | acceptor_gain | 0.9900 |
| 11:64229246:GGT:G | acceptor_gain | 0.9900 |
| 11:64229246:GGTG:G | acceptor_gain | 0.9900 |
| 11:64229342:CCA:C | donor_gain | 0.9900 |
| 11:64229343:CA:C | donor_gain | 0.9900 |
| 11:64229346:T:G | donor_loss | 0.9900 |
| 11:64229348:A:AC | donor_loss | 0.9900 |
| 11:64229473:TCCA:T | acceptor_loss | 0.9900 |
| 11:64229475:CAGGT:C | acceptor_loss | 0.9900 |
| 11:64229476:A:AT | acceptor_loss | 0.9900 |
| 11:64229549:G:GT | donor_gain | 0.9900 |
| 11:64229848:A:AG | acceptor_gain | 0.9900 |
| 11:64229849:G:GG | acceptor_gain | 0.9900 |
AlphaMissense
1918 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:64229334:T:C | F223L | 0.996 |
| 11:64229336:C:A | F223L | 0.996 |
| 11:64229336:C:G | F223L | 0.996 |
| 11:64226834:T:C | F61S | 0.993 |
| 11:64226833:T:C | F61L | 0.991 |
| 11:64226835:C:A | F61L | 0.991 |
| 11:64226835:C:G | F61L | 0.991 |
| 11:64226934:C:A | N94K | 0.989 |
| 11:64226934:C:G | N94K | 0.989 |
| 11:64227120:C:A | H156Q | 0.989 |
| 11:64227120:C:G | H156Q | 0.989 |
| 11:64229329:C:A | A221D | 0.988 |
| 11:64229335:T:C | F223S | 0.988 |
| 11:64229906:A:C | K276N | 0.988 |
| 11:64229906:A:T | K276N | 0.988 |
| 11:64226836:C:A | R62S | 0.987 |
| 11:64227056:T:A | V135D | 0.987 |
| 11:64229325:A:C | S220R | 0.987 |
| 11:64229327:T:A | S220R | 0.987 |
| 11:64229327:T:G | S220R | 0.987 |
| 11:64229341:T:A | V225D | 0.987 |
| 11:64226832:G:C | K60N | 0.985 |
| 11:64226832:G:T | K60N | 0.985 |
| 11:64229289:G:C | G208R | 0.985 |
| 11:64229894:C:G | C272W | 0.984 |
| 11:64229902:C:A | A275D | 0.984 |
| 11:64227110:C:A | P153H | 0.983 |
| 11:64226818:T:C | F56L | 0.982 |
| 11:64226820:C:A | F56L | 0.982 |
| 11:64226820:C:G | F56L | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000136739 (11:64228904 A>G,T), RS1000299009 (11:64228632 T>A,C,G), RS1000445974 (11:64226339 G>A), RS1000774539 (11:64226560 A>C,G), RS1002629045 (11:64230473 G>C), RS1002884392 (11:64228554 C>T), RS1002898986 (11:64224472 T>G), RS1002932120 (11:64230670 C>A,G,T), RS1003263805 (11:64228908 G>A,T), RS1003822218 (11:64230471 G>A,C), RS1004128134 (11:64227785 G>A), RS1004349649 (11:64228965 C>G), RS1004479954 (11:64228416 G>C), RS1005284811 (11:64230754 G>A), RS1005355150 (11:64230525 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004132_98 | Crohn’s disease | 5.000000e-06 |
| GCST010136_47 | Fruit consumption | 9.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 2 |
| Valproic Acid | increases expression, increases methylation | 2 |
| GSK-J4 | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E2EZ | HAP1 NUDT22 (-) 1 | Cancer cell line | Male |
| CVCL_E2F0 | HAP1 NUDT22 (-) 2 | Cancer cell line | Male |
| CVCL_E2F1 | HAP1 NUDT22 (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.